Researchers from the Josep Carreras Leukaemia Research Institute have found that the efficacy of varni-cel, a CAR-T infusion ...

Discover five T cell engager companies that have emerged in recent times, as this class of therapeutics is set to take off.

Discover how next-generation "switchable" CAR-T cells could improve both the safety and efficacy of CAR-T therapies.

(MENAFN- AETOSWire) (BUSINESS WIRE ) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data across a range of B-cell malignancies ...

In a pioneering move, MGM Medical College in Indore has launched CAR T cell therapy for blood cancer treatment, making it ...

Maharaja Yashwantrao Hospital in Indore introduces CAR T-cell therapy, a cutting-edge treatment for blood cancer, now affordable for Central India patients. Learn about this innovative immunotherapy ...

Metabolism reprogramming is one of the hallmarks of cancer, which enables cancer cells to utilize nutrients in a low-nutrient environment and maintain bio-viability. The metabolism reprogramming, as a ...

Apollo Cancer Centers, Visakhapatnam on Tuesday said it has introduced CAR-T cell therapy for the first time in the state of ...

ImmPACT’s lead program, IMPT-314, is a CD19/20-targeting chimeric antigen receptor (CAR) T-cell product candidate that Lyell will continue to develop for hematologic malignancies, including large ...

The company's lead candidate is AT-1965, a first-in-class small molecule liposomal formulation, targeting CMTR2 in cancer cells to make them immunologically hot and visible like a virus to B cells. B ...

The development of CAR-T technology in recent years has been a major milestone in the fight against cancer. These sort of ...